CAPRICOR THERAPEUTICS, INC. (CAPR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $732k
- Jun 25 · Unusual
- Form 4 sales
- 14
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineApr 1 2026
Sold 115,000 shares at $30.57 ($3.5M)
Sabar Karimah Es, Director
10b5-1 planSold 100% of holdings ($3.5M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 saleRoutineApr 2 +1 day
Sold 7,529 shares at $32.00 ($241k)
Sabar Karimah Es, Director
10b5-1 planSold 100% of holdings ($241k position)0 shares leftFiling
- 3 Form 4 saleRoutineMay 1 +29 days
Sold 25,000 shares at $31.70 ($793k)
Krasney Karen, EVP, GENERAL COUNSEL
10b5-1 planSold 45% of holdings ($1.8M position)30,547 shares leftFiling
- 4 Form 4 saleRoutineMay 1 same day
Sold 25,000 shares at $31.70 ($793k)
Bergmann Anthony, CHIEF FINANCIAL OFFICER
10b5-1 planSold 75.2% of holdings ($1.1M position)8,223 shares leftFiling
- 5 Form 4 saleNo planJun 24 +54 days
Sold 900 shares at $30.00 ($27k)
Krasney Karen, EVP, GENERAL COUNSEL
No 10b5-1 planSold 2.9% of holdings ($943k position)30,547 shares leftFiling
- 6 Form 4 saleNo planJun 24 same day
Sold 900 shares at $30.00 ($27k)
Bergmann Anthony, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 7.4% of holdings ($364k position)11,223 shares leftFiling
- 7 Form 4 saleUnusualJun 25 +1 day
Sold 24,100 shares at $30.38 ($732k)
Krasney Karen, EVP, GENERAL COUNSEL
No 10b5-1 planSold 44.1% of holdings ($1.7M position)30,547 shares left1x usual sizeFiling
- 8 Form 4 saleUnusualJun 25 same day
Sold 24,100 shares at $30.38 ($732k)
Bergmann Anthony, CHIEF FINANCIAL OFFICER
No 10b5-1 planSold 68.2% of holdings ($1.1M position)11,223 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (14)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Bergmann Anthony | CHIEF FINANCIAL OFFICER | Form 4 sale | 24,100 | $732k | 68.2% | Unusual | SEC |
| Jun 25, 2026 | Krasney Karen | EVP, GENERAL COUNSEL | Form 4 sale | 24,100 | $732k | 44.1% | Unusual | SEC |
| Jun 24, 2026 | Bergmann Anthony | CHIEF FINANCIAL OFFICER | Form 4 sale | 900 | $27k | 7.4% | No plan | SEC |
| Jun 24, 2026 | Krasney Karen | EVP, GENERAL COUNSEL | Form 4 sale | 900 | $27k | 2.9% | No plan | SEC |
| May 1, 2026 | Bergmann Anthony | CHIEF FINANCIAL OFFICER | Form 4 sale | 25,000 | $793k | 75.2% | Routine | SEC |
| May 1, 2026 | Krasney Karen | EVP, GENERAL COUNSEL | Form 4 sale | 25,000 | $793k | 45.0% | Routine | SEC |
| Apr 2, 2026 | Sabar Karimah Es | Director | Form 4 sale | 7,529 | $241k | 100.0% | Routine | SEC |
| Apr 1, 2026 | Sabar Karimah Es | Director | Form 4 sale | 115,000 | $3.5M | 100.0% | Routine | SEC |
| Mar 31, 2026 | Bergmann Anthony | CHIEF FINANCIAL OFFICER | Form 4 sale | 25,000 | $753k | 75.2% | Routine | SEC |
| Mar 31, 2026 | Krasney Karen | EVP, GENERAL COUNSEL | Form 4 sale | 25,000 | $753k | 45.0% | Routine | SEC |
| Apr 17, 2023 | Avat Xavier | Other | Form 4 sale | 14,772 | $949M | 100.0% | Unusual | SEC |
| Mar 28, 2023 | Avat Xavier | Other | Form 4 sale | 3,000 | $12k | 100.0% | Unusual | SEC |
| Jun 29, 2022 | Musket David B | Director | Form 4 sale | 28,215 | $106k | 68.9% | Unusual | SEC |
| Jun 27, 2022 | Musket David B | Director | Form 4 sale | 17,775 | $79k | 30.3% | Unusual | SEC |